ITIH3 and prostate cancer: ITIH3 has also demonstrated antitumoral and antimetastatic properties, making it a potential biomarker for various types of cancer such as pancreatic cancer, prostate cancer, stomach cancer, and lung adenocarcinoma (60–62).